Home » Topics » Regulatory

Regulatory
RSS

Zovirax approved by FDA for recurrent cold sores

Jan. 8, 2003

Zyvox approved for bacterial infections in infants and children

Jan. 8, 2003

Endo submits NDA for extended-release oxymorphone

Jan. 8, 2003

Metformin XT NDA submitted for type 2 diabetes

Jan. 8, 2003

Restasis receives FDA approval

Jan. 7, 2003

Topamax sNDA submitted for migraine prevention

Jan. 7, 2003

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Foradil Certihaler filed for approval in the U.S.

Jan. 3, 2003

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...